Trials / Completed
CompletedNCT00599079
Azithromycin in the Treatment of M. Avium Complex Lung Disease
Open, Noncomparative Trial of Azithromycin in the Treatment of M.Avium Complex (MAC) Lung Disease
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 66 (actual)
- Sponsor
- The University of Texas Health Science Center at Tyler · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To determine the safety and efficacy of azithromycin in the treatment of lung infection with M.avium complex and M. abscessus lung disease.
Detailed description
To study the safety and efficacy of azithromycin in combination treatment for M. abscessus and MAC lung disease
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Azithromycin | Azithromycin Daily Dosage dependent on clinical factos such as age, weight and patient specific health descriptors |
Timeline
- Start date
- 1993-02-01
- Primary completion
- 2008-05-01
- Completion
- 2017-05-18
- First posted
- 2008-01-23
- Last updated
- 2017-05-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00599079. Inclusion in this directory is not an endorsement.